Form 4 holding
10%+ Owner
CinCor Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 3,630,103
- Estimated value
- $104,365,461
- Report date
- 11 Jan 2022
- Price
- $28.75
- Ownership
- Direct
CinRx Pharma, LLC
Insider Reports History
- Reporting-owner location
- Cincinnati, OH
- Latest reporting-owner signature
-
CinRx Pharma, LLC, By /s/ Jonathan Isaacsohn, CEO
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for CinRx Pharma, LLC
Form 4 holding
10%+ Owner
CinCor Pharma, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 11 Jan 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
CinCor Pharma, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 11 Jan 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by CinRx Pharma, LLC
4
CinCor Pharma, Inc.
- Report period
- 11 Jan 2022
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 13 Jan 2022, 15:40
- Role
- 10%+ Owner
- Next action
- Open filing details
3
CinCor Pharma, Inc.
- Report period
- 06 Jan 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 10 Jan 2022, 15:12
- Role
- 10%+ Owner
- Next action
- Open filing details